Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Is Pfizer Stock a Buy?
The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.
Here's Why Pfizer (PFE) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank,
Pfizer Inc. stock outperforms competitors on strong trading day
Shares of Pfizer Inc. PFE rose 1.65% to $26.44 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,118.71 and the Dow Jones Industrial Average DJIA rising 0.
16h
Pfizer Target of Unusually Large Options Trading (NYSE:PFE)
Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...
9d
What To Expect From PFE Stock In 2025?
In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...
1d
Jefferies Keeps Their Buy Rating on Pfizer (PFE)
In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...
MarketWatch
1mon
Pfizer Boost Quarterly Dividend by 2.4% to 43c
Pfizer
on Thursday said it will raise its quarterly dividend by 2.4%. The
New
York
-based drug company on Thursday said its board increased its cash dividend to 43 cents a share from 42 cents.
5d
The Smartest Dividend Stocks to Buy With $100 Right Now
That's especially the case when you invest in stocks that pay you to own them. I'm referring to dividend stocks, of course.
10d
Pfizer (PFE) Receives a Hold from Citi
Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...
10d
Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund
Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback